Bacteria resistant to last-resort antibiotic, missed by standard tests

March 6, 2018, Emory University
Enterobacteriaceae. Citrobacter freundii, one member of the family. Credit: Public Domain

Emory microbiologists have detected "heteroresistance" to colistin, a last-resort antibiotic, in already highly resistant Klebsiella pneumoniae, a bacterium that causes blood, soft tissue and urinary tract infections.

The results are scheduled for publication in mBio.

David Weiss, PhD, director of the Emory Antibiotic Resistance Center, and his colleagues had observed heteroresistance to colistin in other bacteria, called Enterobacter, previously.

Carbapenem-resistant Enterobacteriaceae (CRE), which include Klebsiella, were listed as one of the top three urgent antibiotic resistant threats in 2013 by the Centers for Disease Control and Prevention. Various types of Klebsiella are estimated to be responsible for 10 percent of infections acquired in .

"This is concerning because Klebsiella is a more common cause of than Enterobacter, and these isolates were carbapenem-resistant, which means that they might actually be treated with colistin," says Weiss, professor of medicine at Emory University School of Medicine and Emory Vaccine Center. "To our knowledge, this type of heteroresistant Klebsiella has not been observed in the United States before."

The first author of the paper is Immunology and Molecular Pathogenesis graduate student Victor Band. Co-authors include Sarah Satola, PhD, Eileen Burd, PhD, Monica Farley, MD and Jesse Jacob, MD. Burd is director of clinical microbiology lab at Emory University Hospital and Farley is director of the Department of Medicine's Division of Infectious Diseases. Weiss's lab is based at the Yerkes National Primate Research Center, Emory University.

The bacterial isolates came from urine samples from two patients in Atlanta-area hospitals as part of the nationwide Multi-site Gram-Negative Surveillance Initiative, part of the CDC-funded Emerging Infections Program.

Heteroresistance means that bacterial resistance to particular antibiotics is harder to monitor. Heteroresistance is caused by a minor subpopulation of resistant bacteria which are genetically identical to the rest of the susceptible bacteria.

The bacterial isolates described in the mBio paper were not detectable with current diagnostic tests, although it was possible to see them by waiting an extra 24 hours for the resistant population to grow out. It appears that maintaining colistin resistance all the time is disadvantageous for bacteria. Probing the mechanism of heteroresistance, Weiss and his colleagues were able to see a signature of colistin resistance, in terms of genes turned on and off.

In a mouse model of peritonitis (body cavity infection), infection with the heteroresistant isolates was lethal and untreatable by colistin. Colistin is viewed as a last resort measure for bacterial infections that are resistant to other drugs, partly because it is poisonous to the kidneys.

"Clinical laboratories should consider testing for heteroresistance to colistin if this last-line antibiotic is required for treatment," the authors say. "However, the extra time required is a downside. Novel diagnostics that rapidly and accurately detect heteroresistance are needed."

Explore further: Resistance to last-line antibiotic makes bacteria resistant to immune system

More information: Victor I. Band et al, Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection, mBio (2018). DOI: 10.1128/mBio.02448-17

Related Stories

Resistance to last-line antibiotic makes bacteria resistant to immune system

May 21, 2013
Bacteria resistant to the antibiotic colistin are also commonly resistant to antimicrobial substances made by the human body, according to a study in mBio, the online open-access journal of the American Society for Microbiology. ...

Researchers discover novel colistin resistance gene mcr-3 in Escherichia coli

June 27, 2017
Researchers have now discovered a new mobile colistin resistance gene, mcr-3, in E. coli of pig origin. The novel mcr-3 gene was discovered when a colistin-resistant Escherichia coli isolate tested negative for both mcr-1 ...

Multi-drug resistant bacteria in China

January 28, 2017
The mcr-1 gene—a gene that makes bacteria resistant to colistin, an antibiotic of last resort, and that is transferrable between bacteria—has been found in a wide variety of strains of Escherichia coli in China following ...

Recommended for you

Recent clinical trial finds tamsulosin not effective in kidney stone passage

June 18, 2018
The latest research into finding medications to aid the passage of ureteral or kidney stones has shown that tamsulosin is not effective for patients across the board. Previously approved to help men experiencing enlarged ...

Research finds new way to determine protection of Men B vaccine against different strains

June 18, 2018
Researchers at the University of Leicester and Meningococcal Reference Unit have developed a new approach to assess the effectiveness of the Men B vaccine, Bexsero, against different strains that cause meningococcal meningitis ...

Novel molecular target to prevent scarring of the lung blood vessels identified

June 13, 2018
Pulmonary arterial hypertension, a severe form of cardiopulmonary disease in which the arteries that transport blood from the heart to the lungs become thickened, constricted, and scarred, is a disease for which there is ...

Lineage of TB traced and compared to early human migration

June 13, 2018
A team of researchers from the University of Wisconsin, the University of Iowa and the Norwegian Institute of Public Health has carried out genetic studies of tuberculosis to learn more about its lineage and to compare it ...

Fast-acting cholera vaccine could curb outbreaks

June 13, 2018
A tricked-out cholera vaccine starts protecting against the deadly disease within a day, experiments in rabbits suggest. The rapid protection offered by this designer vaccine may one day limit the spread of cholera outbreaks, ...

Finally, hope for a syphilis vaccine

June 12, 2018
Despite efforts to eradicate it, syphilis is on the rise. Until now, most health agencies focused on treating infected people and their sex partners but new discoveries may make a vaccine possible, UConn Health researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.